PMID: 6989001Apr 1, 1980Paper

Pretransplant T cell levels and renal allograft survival rates

Surgery
C H UittenbogaartR N Fine

Abstract

Total rosette forming cell (TRFC) levels were measured in 50 patients awaiting cadaveric renal transplantation. Preliminary data show a statistically significant difference in allograft survival in patients with low TRFC levels before transplant as compared with patients with medium or high TRFC levels. Pretransplant TRFC levels may be predictive of a nonresponder status and portend a favorable renal allograft outcome.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.